From what 7 stock analysts predict, the share price for Sage Therapeutics Inc (SAGE) might increase by 1.93% in the next year. This is based on a 12-month average estimation for SAGE. Price targets go from $20.00 to $30.00. The majority of stock analysts believe SAGE is a buy. Please note analyst price targets are not guaranteed and could be missed completely.
SAGE is a stock in Health Care which has been forecasted to be worth $24.29 as an average. On the higher end, the forecast price is $30.00 USD by ritu baral from TD Cowen and on the lower end SAGE is forecasted to be $20.00 by vikram purohit from Morgan Stanley.
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
---|---|---|---|---|
laura chico Wedbush | Hold | $24.0 | maintained | Jan 29, 2024 |
joon lee Truist Financial | Hold | $22.0 | maintained | Jan 22, 2024 |
tazeen ahmad Bank of America Securities | Hold | $30.0 | maintained | Jan 17, 2024 |
jay olson Oppenheimer | Hold | $23.0 | maintained | Jan 11, 2024 |
ritu baral TD Cowen | Buy | $30.0 | maintained | Jan 9, 2024 |
paul matteis Stifel Nicolaus | Hold | $20.0 | maintained | Dec 18, 2023 |
neena bitritto garg Deutsche Bank | Hold | $21.0 | initiatedcoverage | Dec 11, 2023 |
george farmer Scotiabank | Buy | $24.0 | rated | Nov 8, 2023 |
brian abrahams RBC Capital | Hold | $21.0 | maintained | Nov 8, 2023 |
uy ear Mizuho Securities | Hold | $20.0 | maintained | Nov 8, 2023 |
sumant kulkarni Canaccord Genuity | Hold | $21.0 | maintained | Nov 7, 2023 |
marc goodman Leerink Partners | Hold | $18.0 | maintained | Nov 7, 2023 |
salveen richter Goldman Sachs | Hold | $25.0 | maintained | Oct 13, 2023 |
anupam rama J.P. Morgan | Buy | $24.0 | maintained | Aug 22, 2023 |
vikram purohit Morgan Stanley | Hold | $20.0 | maintained | Aug 9, 2023 |
ami fadia Needham | Hold | None | downgraded | Aug 8, 2023 |
douglas tsao H.C. Wainwright | Hold | $27.0 | reiterated | Aug 8, 2023 |
yasmeen rahimi Piper Sandler | Buy | $100.0 | rated | Aug 7, 2023 |
akash tewari Jefferies | Hold | $36.0 | maintained | Apr 10, 2023 |
danielle brill Raymond James | Hold | None | maintained | Mar 8, 2023 |
In 2023, SAGE generated $0 in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that SAGE's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2019
Revenue From 2020
Revenue From 2021
Revenue From 2022
SOFI-USD
$8.33
TMUS-USD
$161.76
TXN-USD
$162.4
UPST-USD
$33.9
$27.88
TXG-USD
$49.11